| Entry |
|
| Name |
HSPG2
|
| Definition |
heparan sulfate proteoglycan 2 (perlecan)
|
| Pathway |
| ECM-receptor interaction | | Hepatitis B | | Proteoglycans in cancer |
|
| Disease |
| Heparan sulfate proteoglycan gene defects |
|
| Brite |
KEGG Orthology (KO) [BR:ko00001]
Environmental Information Processing
Signaling molecules and interaction
04512 ECM-receptor interaction
K06255 HSPG2; heparan sulfate proteoglycan 2 (perlecan)
Human Diseases
Cancers
05205 Proteoglycans in cancer
K06255 HSPG2; heparan sulfate proteoglycan 2 (perlecan)
Infectious diseases
05161 Hepatitis B
K06255 HSPG2; heparan sulfate proteoglycan 2 (perlecan)
Cell adhesion molecules and their ligands [BR:ko04516]
2. Integrin Family
Beta1 integrins
VLA-2
ITGB1; integrin beta 1
K06255 HSPG2; heparan sulfate proteoglycan 2 (perlecan)
7. Others
DAG1; dystroglycan 1
K06255 HSPG2; heparan sulfate proteoglycan 2 (perlecan)
Proteoglycans [BR:ko00535]
Extracellular matrix (ECM) proteoglycans
Basement membrane proteoglycans
K06255 HSPG2; heparan sulfate proteoglycan 2 (perlecan)
 |
| Genes |
HSA: | | PTR: | | PPS: | | GGO: | | PON: | | MCC: | | MMU: | | CFA: | | AML: | | FCA: | | BTA: | | SSC: | | ECB: | | MDO: | | SHR: | | OAA: | | GGA: | | XTR: | | DRE: | | TRU: | | OLA: | | BFO: | | CIN: | | SPU: | | NVE: | | TAD: | | » show all
   |
| Reference |
|
| Authors |
Whitelock JM, Melrose J, Iozzo RV |
| Title |
Diverse cell signaling events modulated by perlecan. |
| Journal |
Biochemistry 47:11174-83 (2008) |